Business Wire

TOM FORD Unveils New Runway Lip Color Campaign Starring Angelina Jolie

Share

Always iconic. TOM FORD Runway Lip Color is the ultimate fashion accessory.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240822713897/en/

TOM FORD Runway Lip Color Campaign starring Angelina Jolie. (Photo: Business Wire)

Introducing Angelina Jolie for the new TOM FORD Runway Lip Color in a campaign that brings together two icons. An inveterate trailblazer, Jolie drives her personal narrative with strength, confidence and an uncompromising commitment to self-expression. An Academy Award, Golden Globe, and Tony Award winner, Jolie has established herself as an international icon in film, theater and fashion. She goes beyond what the role of an artist can be, parlaying her influence through her humanitarian work, with over 20 years in the field, focusing on refugees and human rights. Additionally, as a fashion entrepreneur, she recently founded Atelier Jolie, a hub for artists, empowering people to participate in creating their own fashion, with a focus on sustainability.

The campaign is lensed by Mert Alas and Marcus Piggott, a cinematic homage to feminine beauty and its power. Launching on September 3, the campaign images and video show Jolie studying for a role, a character that loves the camera almost as much as it loves her. A portrait of a woman who makes everything in her gaze her own, drawing confidence from the power of her signature shade: 16 Scarlet Rouge.

Believing in its transformative power, there is nothing more dramatic than a strong lip. TOM FORD BEAUTY first entered the lip category with the debut of the Private Blend Lip Color Collection in 2010. The new TOM FORD Runway Lip Color, a staple on the runway, evolves as a true luxury piece to usher in a new era. The formula is crafted with a hydrating complex that conditions lips in decadent emollience and rich, fade-resistant color. Debuting in September, the collection will feature 18 shades, 10 existing and 8 new.

TOMFORD.COM

View source version on businesswire.com: https://www.businesswire.com/news/home/20240822713897/en/

Contacts

kaholmes@tomfordbeauty.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer14.9.2024 18:45:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced new early clinical data for INCB123667, a highly selective, potential first-in-class CDK2 inhibitor, in patients with advanced solid tumors. The trial results, presented during a mini-oral presentation at the European Society of Medical Oncology (ESMO) with new, updated data shared during the Company’s investor event, highlight the potential of INCB123667 as a differentiated treatment option for cancers with increased Cyclin E1 activity, amplification and/or overexpression in cells predictive of CDK2 dependency. In the trial, patients with advanced or metastatic solid tumors (n=205) – including ovarian cancer, endometrial cancer, gastrointestinal cancer, HR+/HER2- breast cancer and triple negative breast cancer, among others – received varying doses of INCB123667 ranging from 50mg to 150mg using once-daily (QD) and twice-daily (BID) dosing schedules. New data from the Phase 1b dose expansion portion of the trial (data cut-off August 26, 2024) presen

Incyte’s Retifanlimab (Zynyz ® ) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium14.9.2024 16:30:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced results from the Phase 3 POD1UM-303/InterAACT2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with platinum-based chemotherapy (carboplatin–paclitaxel) for the treatment of adults with inoperable locally recurrent or metastatic squamous cell anal carcinoma (SCAC). These data were featured today in a Presidential Symposium (LBA 2) at the European Society for Medical Oncology (ESMO) Congress 2024, held in Barcelona and virtually. The POD1UM-303/InterAACT2 trial results build on previously announced topline results, showing that the study met its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with SCAC not previously treated with systemic therapy, as assessed by blinded independent central review (BICR) using RECIST v1.1. Adding retifanlimab to standard of care chemotherapy res

Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience14.9.2024 10:00:00 CEST | Press release

Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This collaboration integrates Bitmovin’s renowned Player and Analytics suite into Irdeto Experience, the award-winning streaming platform trusted by top-tier operators worldwide. Together, they will provide streaming service providers, content owners, and pay-TV operators with cutting-edge solutions that address the critical need for low-latency streaming. The combination of Irdeto’s expertise in security and Bitmovin’s preeminent player offers a powerful and comprehensive solution. This joint offering allows operators to benefit from smooth, high-resolution streaming and advanced advertising and security features. The collaboration also enables operators to extend device reach by covering a wider range of devices in the Smart TV market. Whether for liv

SCF Acquires Newpark Fluids Systems14.9.2024 02:40:00 CEST | Press release

SCF Partners, Inc. (“SCF”) is pleased to announce its acquisition of the Newpark Fluids Systems business (“NFS”), a leading global pure-play oil & gas and geothermal fluids solution provider, from Newpark Resources Inc. (NYSE: NR). Newpark Fluids Systems provides a full range of drilling & completion products and related technical services supported by an innovative digital modeling software suite, global supply chain and infrastructure to enhance the efficiency and productivity of our customers’ performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240913427560/en/ Newpark Fluid Systems’ CEO, David Paterson, commented, “We are thrilled to partner with SCF. This new partnership will be a source of enormous value creation for both our customers and the entire Newpark Fluids Systems team. Our global strategic growth plan will now accelerate under a new and focused board with significant energy experience and commitment.

Important Looking Pirates Wins Its Third Creative Arts Emmy Award for Its Work on the FX Series Shōgun13.9.2024 18:00:00 CEST | Press release

Philip Engström, VFX Supervisor and Chelsea Mirus, VFX Production Manager represented Important Looking Pirates (“ILP”) on the Shōgun ballot at the award ceremony in Los Angeles, winning the Emmy in the Special Visual Effects In A Season Or A Movie category. ILP had the honour of contributing to 7 out of the 10 episodes for the FX series, which was led by overall VFX supervisor Michael Cliett, and won a record-breaking 14 Creative Arts Emmy awards and is poised to extend that streak at the Primetime Emmys later this week. With an emphasis on historical authenticity, ILP was responsible for large-scale full CG environments, vast crowd work, a devastating landslide and sweeping marine simulations. In addition to Shōgun, ILP was recognized with nominations for 2 of the remaining 4 visual effects nominees at this year’s awards: Netflix’s Avatar: The Last Airbender with Niklas Jacobson as VFX Supervisor and Amazon’s Fallout with Ahmed Gharraph as VFX Supervisor. Additionally, the studio was

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye